Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial

Ajay Subramanian, Serey C.L. Nouth, Neda Nemat-Gorgani, Shaghayegh Soudi, Karla V. Ballman, Rachel S. Heise, Claire Johns, Timothy J. Sears, Siyer Roohani, Reinhardt Krcek, Angela M. Hong, Kent J. Weinhold, Matt van de Rijn, Brian E. Brigman, Richard F. Riedel, Yvonne M. Mowery, David G. Kirsch, Everett J. Moding

Open source

DOI: 10.1200/jco-26-00769
Published: 2026-09-09
Container: Journal of Clinical Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/jco-26-00769,
  title = {Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial},
  author = {Ajay Subramanian and Serey C.L. Nouth and Neda Nemat-Gorgani and Shaghayegh Soudi and Karla V. Ballman and Rachel S. Heise and Claire Johns and Timothy J. Sears and Siyer Roohani and Reinhardt Krcek and Angela M. Hong and Kent J. Weinhold and Matt van de Rijn and Brian E. Brigman and Richard F. Riedel and Yvonne M. Mowery and David G. Kirsch and Everett J. Moding},
  year = {2026},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco-26-00769},
  url = {https://doi.org/10.1200/jco-26-00769}
}

RIS

TY  - JOUR
TI  - Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial
AU  - Ajay Subramanian
AU  - Serey C.L. Nouth
AU  - Neda Nemat-Gorgani
AU  - Shaghayegh Soudi
AU  - Karla V. Ballman
AU  - Rachel S. Heise
AU  - Claire Johns
AU  - Timothy J. Sears
AU  - Siyer Roohani
AU  - Reinhardt Krcek
AU  - Angela M. Hong
AU  - Kent J. Weinhold
AU  - Matt van de Rijn
AU  - Brian E. Brigman
AU  - Richard F. Riedel
AU  - Yvonne M. Mowery
AU  - David G. Kirsch
AU  - Everett J. Moding
PY  - 2026
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco-26-00769
UR  - https://doi.org/10.1200/jco-26-00769
ER  -

APA

Subramanian, A., Nouth, S. C., Nemat-Gorgani, N., Soudi, S., Ballman, K. V., Heise, R. S., Johns, C., Sears, T. J., Roohani, S., Krcek, R., Hong, A. M., Weinhold, K. J., Rijn, M. V. D., Brigman, B. E., Riedel, R. F., Mowery, Y. M., Kirsch, D. G., & Moding, E. J. (2026). Personalized Circulating Tumor DNA Analysis for Predicting Outcomes and Tracking Response to Radiotherapy and Pembrolizumab in Localized Sarcomas: Analysis of the SU2C-SARC032 Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-00769

Source records

crossref · retrieved 2026-09-26T14:26:04.932Z